CANC

ETF / Mutual Fund
NASDAQ
Tema Oncology ETF
Price Chart
Overview

About CANC

Under normal circumstances, the fund seeks to achieve its investment objective by investing at least 80% of its net assets, which include borrowings for investment purposes, in publicly listed companies that derive at least 50% of revenues from oncology. The fund is non-diversified.

AUM
Volume
165.7K
Avg. Volume
168.1K
Expense Ratio

Fund Information

Exchange
NASDAQ
Sector
Risk & Correlation Analysis
Market Correlation
0.32
Low Correlation
Volatility
Medium (0.36)
Relative to market

Macro Factor Sensitivities

Interest Rates
Low Sensitivity
Inflation
Low Sensitivity
GDP Growth
Low Sensitivity
Liquidity
Low Sensitivity
Commodity Prices
Low Sensitivity
Credit Quality
Medium Sensitivity
Portfolio Impact
Forecasts & Predictions

Premium Forecasts

Get AI-powered price predictions, technical analysis, and market forecasts for CANC.

1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential

Technical Analysis

Based on technical indicators and chart patterns, CANC shows...

AI Sentiment Analysis

Market sentiment analysis indicates...

Key Statistics
AUM
Volume165.7K
Expense Ratio
Important Dates
Next Dividend
Next Earnings
Related Securities

PortfolioPilot Analysis

Get AI-powered insights on how CANC fits into your investment strategy and portfolio diversification.

Pricing info last updated June 17, 2025 (after market close)Other info last updated April 2, 2025